Skip to contentSkip to Braille Studio

Library / Laws / 114th Congress / Senate Bills / S. 481

S. 481

To amend the Controlled Substances Act and the Federal Food, Drug, and Cosmetic Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2015-02-1210.2K⠃⠗⠋
Reported in Senate2015-02-1223.1K⠃⠗⠋